Steroidal hormones, their derivatives and structural analogues: oestrogens and progestogens

In 2024, steroidal hormones, their derivatives and structural analogues: oestrogens and progestogens trade exhibited slight decline, with global flows reaching $742,964,319 and a three-year compound annual growth rate of -2.3% (five-year: -2.0%). The all-time peak of $1,222,982,677 was recorded in 2012; the current level is 39% below that high-water mark.

Over the 30-year observation window (1995–2024), 55% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is steady (-0.2% acceleration).

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.188). The three largest exporters — China ($257.6M), Italy ($148.8M), and Netherlands ($95.5M) — collectively dominate supply flows. The leading exporter has grown at -2.1% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.054). The three largest import markets are Netherlands ($74.9M), India ($72.2M), and United States ($71.7M). The largest importing market sources from 25 different supplying countries.

The dominant trade corridor is China → Italy at $42.2M, representing 75.6% of the importer's total demand.

The volatility score for steroidal hormones, their derivatives and structural analogues: oestrogens and progestogens is 2 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.